BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 233 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $442,000 | -26.9% | 7,551 | 0.0% | 0.01% | -10.0% |
| Q4 2019 | $605,000 | +9.0% | 7,551 | 0.0% | 0.01% | -9.1% |
| Q3 2019 | $555,000 | -22.1% | 7,551 | 0.0% | 0.01% | -26.7% |
| Q2 2019 | $712,000 | +38.0% | 7,551 | +17.1% | 0.02% | +25.0% |
| Q1 2019 | $516,000 | +41.8% | 6,451 | -4.4% | 0.01% | +33.3% |
| Q4 2018 | $364,000 | -65.5% | 6,751 | -50.0% | 0.01% | -43.8% |
| Q3 2018 | $1,054,000 | +170.3% | 13,502 | +119.5% | 0.02% | +100.0% |
| Q2 2018 | $390,000 | -20.6% | 6,151 | +15.0% | 0.01% | -27.3% |
| Q1 2018 | $491,000 | +69.3% | 5,351 | +39.0% | 0.01% | +175.0% |
| Q4 2017 | $290,000 | – | 3,851 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |